COX-2 and beyond: Approaches to prostaglandin inhibition in human disease

Nat Rev Drug Discov. 2003 Nov;2(11):879-90. doi: 10.1038/nrd1225.
No abstract available

Publication types

  • Review

MeSH terms

  • Arteriosclerosis / drug therapy*
  • Biological Availability
  • Cardiovascular Diseases / drug therapy*
  • Cyclooxygenase Inhibitors / adverse effects
  • Cyclooxygenase Inhibitors / pharmacokinetics
  • Cyclooxygenase Inhibitors / therapeutic use*
  • Half-Life
  • Humans
  • Hypertension / drug therapy*
  • Prostaglandin-Endoperoxide Synthases / metabolism
  • Prostaglandin-Endoperoxide Synthases / physiology*
  • Thrombosis / chemically induced

Substances

  • Cyclooxygenase Inhibitors
  • Prostaglandin-Endoperoxide Synthases